Search Results 1781-1790 of 21379 for anti-TNF drugs

  1. Antibiotic Therapies Clinical Trials - Mayo Clinic Research

    The purpose of this study is to describe the results of antibiotic resistant organisms after the use of topical antibiotics in the treatment of chronic ...

  2. Gastric acid suppression medications increase risk for recurrence of Clostridium difficile infection - Mayo Clinic News Network

    C-diff is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. The study is published in JAMA Internal ...

  3. Hodgkin lymphoma (Hodgkin disease) - Care at Mayo Clinic

    Mayo Clinic radiation oncologists plan and deliver radiation therapy safely using advances such as volumetric modulated arc therapy and proton therapy. These ...

  4. A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus - Mayo Clinic

    drug. 2. Previous anti-cancer hormonal treatment or anti-cancer immunotherapy within 2 weeks of the first administration of trial drug. 3. Previous treatment ...

  5. Teriparatide (Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  6. Formoterol (Inhalation Route) Description and Brand Names - Mayo Clinic

    Formoterol is used together with other medicines (eg, inhaled corticosteroids) to treat asthma and prevent bronchospasm in patients with asthma. When used ...

  7. Glofitamab-Gxbm (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Columvi. Descriptions. Glofitamab-gxbm injection is used to ...

  8. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Has any unresolved toxicity grade > 1 from previous anti-cancer therapy. Subject use of immunosuppressive medication within 14 days before the Cycle 1 Day 1:.

  9. Thalidomide (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  10. A Study to Evaluate the Use of Adipose-derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis - Mayo Clinic

    Patients receiving treatment with hematopoietic growth factors or anti-vasculogenesis or anti-angiogenesis treatment (e.g., anti-VEGF). Patients requiring ...